FDA recall D-0745-2022

The Ritedose Corporation · Class III · drug

Product

23.4% Sodium Chloride Injection, 120 mEq per 30 mL (4 mEq/mL), 50 mL prefilled syring, Rx Only, RITEDOSE, 503B Outsourcing Facility, A Division of the RITEDOSE Corporation, 1 Technology Circle, Columbia, SC 29203, 1-866-994-4670, NDC: 65302-509-30, barcode N (01) 003 65302 50930 0

Reason for recall

Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL.

Distribution

Nationwide in the USA

Key facts

Status
Terminated
Initiation date
2022-04-01
Report date
2022-04-13
Termination date
2022-12-02
Voluntary/Mandated
Voluntary: Firm initiated
Location
Columbia, SC, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0745-2022